{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:27:05Z","timestamp":1791671225522,"version":"4.3.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Research Foundation Flanders (FWO) (G0A5316N and SBO-Saphir), the KU Leuven Research Council"},{"name":"the International (Regional) Cooperation and Exchange Project of National Natural Science Foundation of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59398-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:17:35Z","timestamp":1746609455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-9428","authenticated-orcid":false,"given":"Eline","family":"Pellaers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-8719","authenticated-orcid":false,"given":"Julie","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6390-8593","authenticated-orcid":false,"given":"Lore","family":"Wils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4944-2595","authenticated-orcid":false,"given":"Alexe","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anayat","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siska","family":"Van Belle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-3874","authenticated-orcid":false,"given":"Frauke","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-1565","authenticated-orcid":false,"given":"Zeger","family":"Debyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"59398_CR1","first-page":"1","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. The reservoir of latent HIV. Front. Cell. Infect. Microbiol. 12, 1\u201315 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"59398_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.663843","volume":"12","author":"M Younas","year":"2021","unstructured":"Younas, M. et al. Residual viremia is linked to a specific immune activation profile in HIV-1-infected adults under efficient antiretroviral therapy. Front. Immunol. 12, 1\u20139 (2021).","journal-title":"Front. Immunol."},{"key":"59398_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","volume":"166","author":"E Abner","year":"2019","unstructured":"Abner, E. & Jordan, A. HIV \u201cshock and kill\u201d therapy: In need of revision. Antiviral Res. 166, 19\u201334 (2019).","journal-title":"Antiviral Res."},{"key":"59398_CR4","doi-asserted-by":"crossref","unstructured":"Janssens, J., Bruggemans, A., Christ, F. & Debyser, Z. Towards a Functional Cure of HIV-1: Insight into the chromatin landscape of the provirus. Front. microbiol. 12, 636642 (2021).","DOI":"10.3389\/fmicb.2021.636642"},{"key":"59398_CR5","first-page":"1","volume":"11","author":"Z Debyser","year":"2019","unstructured":"Debyser, Z., Vansant, G., Bruggemans, A., Janssens, J. & Christ, F. Insight in HIV integration site selection provides a block-and-lock strategy for a functional cure of HIV infection. Viruses 11, 1\u201312 (2019).","journal-title":"Viruses"},{"key":"59398_CR6","doi-asserted-by":"crossref","unstructured":"Moranguinho, I. & Valente, S. T. Block-and-lock: New horizons for a cure for hiv-1. Viruses 12, (2020).","DOI":"10.3390\/v12121443"},{"key":"59398_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2020.00424","volume":"10","author":"CL Ahlenstiel","year":"2020","unstructured":"Ahlenstiel, C. L., Symonds, G., Kent, S. J. & Kelleher, A. D. Block and lock HIV cure strategies to control the latent reservoir. Front. Cell. Infect. Microbiol. 10, 1\u201313 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"59398_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12010084","volume":"12","author":"G Vansant","year":"2020","unstructured":"Vansant, G., Bruggemans, A., Janssens, J. & Debyser, Z. Block-and-lock strategies to cure HIV infection. Viruses 12, 1\u201317 (2020).","journal-title":"Viruses"},{"key":"59398_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02662-18","volume":"10","author":"S Mediouni","year":"2019","unstructured":"Mediouni, S. et al. Didehydro-cortistatin a inhibits HIV-1 by specifically binding to the unstructured basic region of tat. mBio 10, 1\u201319 (2019).","journal-title":"mBio"},{"key":"59398_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1089\/aid.2018.0118","volume":"34","author":"S Castro-Gonzalez","year":"2018","unstructured":"Castro-Gonzalez, S., Colomer-Lluch, M. & Serra-Moreno, R. Barriers for HIV Cure: The latent reservoir. AIDS Res. Hum. Retroviruses 34, 739\u2013759 (2018).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"59398_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","volume":"1","author":"Y Kim","year":"2018","unstructured":"Kim, Y., Anderson, J. L. & Lewin, S. R. Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV. Cell Host Microbe 1, 14\u201326 (2018).","journal-title":"Cell Host Microbe"},{"key":"59398_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2016.12.003","volume":"38","author":"G Darcis","year":"2017","unstructured":"Darcis, G., Van Driessche, B. & Van Lint, C. HIV Latency: Should we shock or lock? Trends Immunol 38, 217\u2013228 (2017).","journal-title":"Trends Immunol"},{"key":"59398_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-092112-152941","volume":"66","author":"MS Dahabieh","year":"2015","unstructured":"Dahabieh, M. S., Battivelli, E. & Verdin, E. Understanding HIV latency: The road to an HIV cure. Annu. Rev. Med. 66, 407\u2013421 (2015).","journal-title":"Annu. Rev. Med."},{"key":"59398_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005142","volume":"11","author":"OS S\u00f8gaard","year":"2015","unstructured":"S\u00f8gaard, O. S. et al. The depsipeptide romidepsin reverses HIV-1 latency in vivo. PLoS Pathog 11, 1\u201322 (2015).","journal-title":"PLoS Pathog"},{"key":"59398_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"NM Archin","year":"2012","unstructured":"Archin, N. M. et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487, 482\u2013485 (2012).","journal-title":"Nature"},{"key":"59398_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2119\/molmed.2011.00076","volume":"17","author":"S Matalon","year":"2011","unstructured":"Matalon, S., Rasmussen, T. A. & Dinarello, C. A. Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir. Mol. Med. 17, 466\u2013472 (2011).","journal-title":"Mol. Med."},{"key":"59398_CR17","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-10-67","volume":"10","author":"C Van Lint","year":"2013","unstructured":"Van Lint, C., Bouchat, S. & Marcello, A. HIV-1 transcription and latency: An update. Retrovirology 10, 1 (2013).","journal-title":"Retrovirology"},{"key":"59398_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","volume":"19","author":"MP Davenport","year":"2019","unstructured":"Davenport, M. P. et al. Functional cure of HIV: the scale of the challenge. Nat. Rev. Immunol. 19, 45\u201354 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"59398_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2012.05.016","volume":"12","author":"G Mousseau","year":"2012","unstructured":"Mousseau, G. et al. An Analog of the natural steroidal alkaloid cortistatin a potently suppresses tat-dependent HIV transcription. Cell Host Microbe 12, 97\u2013108 (2012).","journal-title":"Cell Host Microbe"},{"key":"59398_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00465-15","volume":"6","author":"G Mousseau","year":"2015","unstructured":"Mousseau, G. et al. The tat inhibitor didehydro-cortistatin a prevents HIV-1 reactivation from latency. mBio 6, 1\u201314 (2015).","journal-title":"mBio"},{"key":"59398_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.chom.2011.11.002","volume":"10","author":"M Ott","year":"2011","unstructured":"Ott, M., Geyer, M. & Zhou, Q. The control of HIV transcription: Keeping RNA polymerase II on track. Cell Host Microbe 10, 426\u2013435 (2011).","journal-title":"Cell Host Microbe"},{"key":"59398_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.celrep.2017.09.080","volume":"21","author":"CF Kessing","year":"2017","unstructured":"Kessing, C. F. et al. In vivo suppression of HIV rebound by didehydro-Cortistatin A, a \u201cblock-and-lock\u201d strategy for HIV-1 cure. Cell Rep. 21, 600\u2013611 (2017).","journal-title":"Cell Rep."},{"key":"59398_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-019-0267-8","volume":"12","author":"C Li","year":"2019","unstructured":"Li, C., Mousseau, G. & Valente, S. T. Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat. Epigenetics Chromatin 12, 1\u201317 (2019).","journal-title":"Epigenetics Chromatin"},{"key":"59398_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ddtec.2017.11.002","volume":"24","author":"J Blokken","year":"2017","unstructured":"Blokken, J., De Rijck, J., Christ, F. & Debyser, Z. Protein\u2013protein and protein\u2013chromatin interactions of LEDGF\/p75 as novel drug targets. Drug Discov. Today Technol. 24, 25\u201331 (2017).","journal-title":"Drug Discov. Today Technol."},{"key":"59398_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jmb.2006.04.073","volume":"360","author":"M Llano","year":"2006","unstructured":"Llano, M. et al. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF\/p75. J. Mol. Biol. 360, 760\u2013773 (2006).","journal-title":"J. Mol. Biol."},{"key":"59398_CR26","doi-asserted-by":"crossref","unstructured":"Marshall, H. M. et al. Role of PSIP 1\/LEDGF\/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2, 10.1371\/journal.pone.0001340 (2007).","DOI":"10.1371\/journal.pone.0001340"},{"key":"59398_CR27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1101\/gad.1565107","volume":"21","author":"MC Shun","year":"2007","unstructured":"Shun, M. C. et al. LEDGF\/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 21, 1767\u20131778 (2007).","journal-title":"Genes Dev"},{"key":"59398_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nm1329","volume":"11","author":"A Ciuffi","year":"2005","unstructured":"Ciuffi, A. et al. A role for LEDGF\/p75 in targeting HIV DNA integration. Nat. Med. 11, 1287\u20131289 (2005).","journal-title":"Nat. Med."},{"key":"59398_CR29","doi-asserted-by":"crossref","unstructured":"Meehan, A. M. et al. LEDGF\/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog. 5, e1000522 (2009).","DOI":"10.1371\/journal.ppat.1000522"},{"key":"59398_CR30","doi-asserted-by":"crossref","unstructured":"Gijsbers, R. et al. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther. 18, 552\u2013560 (2010).","DOI":"10.1038\/mt.2010.36"},{"key":"59398_CR31","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1093\/nar\/gkac521","volume":"50","author":"A Acke","year":"2022","unstructured":"Acke, A. et al. Expansion microscopy allows high resolution single cell analysis of epigenetic readers. Nucleic Acids Res. 50, e100\u2013e100 (2022).","journal-title":"Nucleic Acids Res."},{"key":"59398_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.virol.2012.09.033","volume":"435","author":"F Christ","year":"2013","unstructured":"Christ, F. & Debyser, Z. The LEDGF\/p75 integrase interaction, a novel target for anti-HIV therapy. Virology 435, 102\u2013109 (2013).","journal-title":"Virology"},{"key":"59398_CR33","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1128\/JVI.80.4.1886-1896.2006","volume":"80","author":"L Vandekerckhove","year":"2006","unstructured":"Vandekerckhove, L. et al. Transient and stable knockdown of the integrase cofactor LEDGF\/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80, 1886\u20131896 (2006).","journal-title":"J. Virol."},{"key":"59398_CR34","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1128\/JVI.00801-06","volume":"80","author":"J De Rijck","year":"2006","unstructured":"De Rijck, J. et al. Overexpression of the lens epithelium-derived growth factor\/p75 integrase binding domain inhibits human immunodeficiency virus replication. J. Virol. 80, 11498\u201311509 (2006).","journal-title":"J. Virol."},{"key":"59398_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nchembio.370","volume":"6","author":"F Christ","year":"2010","unstructured":"Christ, F. et al. Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication. Nat. Chem. Biol. 6, 442\u2013448 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"59398_CR36","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1128\/AAC.00717-12","volume":"56","author":"F Christ","year":"2012","unstructured":"Christ, F. et al. Small-molecule inhibitors of the LEDGF\/p75 binding site of integrase block HIV replication and modulate integrase multimerization. Antimicrob. Agents Chemother. 56, 4365\u20134374 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59398_CR37","doi-asserted-by":"publisher","first-page":"21189","DOI":"10.1074\/jbc.M112.347534","volume":"287","author":"M Tsiang","year":"2012","unstructured":"Tsiang, M. et al. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action. J. Biol. Chem. 287, 21189\u201321203 (2012).","journal-title":"J. Biol. Chem."},{"key":"59398_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ebiom.2016.04.039","volume":"8","author":"LS Vranckx","year":"2016","unstructured":"Vranckx, L. S. et al. LEDGIN-mediated Inhibition of Integrase-LEDGF\/p75 Interaction Reduces Reactivation of Residual Latent HIV. EBioMedicine 8, 248\u2013264 (2016).","journal-title":"EBioMedicine"},{"key":"59398_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-020-00530-4","volume":"17","author":"BA Desimmie","year":"2020","unstructured":"Desimmie, B. A. et al. LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions. Retrovirology 17, 1\u201316 (2020).","journal-title":"Retrovirology"},{"key":"59398_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-019-0472-3","volume":"16","author":"G Vansant","year":"2019","unstructured":"Vansant, G. et al. Impact of LEDGIN treatment during virus production on residual HIV-1 transcription. Retrovirology 16, 1\u201317 (2019).","journal-title":"Retrovirology"},{"key":"59398_CR41","doi-asserted-by":"publisher","first-page":"7801","DOI":"10.1093\/nar\/gkaa536","volume":"48","author":"G Vansant","year":"2020","unstructured":"Vansant, G. et al. The chromatin landscape at the HIV-1 provirus integration site determines viral expression. Nucleic Acids Res. 48, 7801\u20137817 (2020).","journal-title":"Nucleic Acids Res."},{"key":"59398_CR42","doi-asserted-by":"publisher","unstructured":"Janssens, J., De Wit, F., Parveen, N. & Debyser, Z. Single-Cell Imaging Shows That the transcriptional state of the HIV-1 Provirus and Its Reactivation Potential Depend on the Integration Site. mBio https:\/\/doi.org\/10.1128\/mbio.00007-22 (2022).","DOI":"10.1128\/mbio.00007-22"},{"key":"59398_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02328-20","volume":"65","author":"A Bruggemans","year":"2021","unstructured":"Bruggemans, A. et al. GS-9822, a preclinical LEDGIN candidate, displays a block-and- lock phenotype in cell culture. Antimicrob. Agents Chemother. 65, 1\u201317 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59398_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41594-018-0102-0","volume":"25","author":"H Rahnamoun","year":"2018","unstructured":"Rahnamoun, H. et al. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation. Nat. Struct. Mol. Biol. 25, 687\u2013697 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59398_CR45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J. et al. Selective inhibition of tumor oncogenes by disruption of super-. Enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Enhancers. Cell"},{"key":"59398_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/nar\/gks976","volume":"41","author":"Z Li","year":"2013","unstructured":"Li, Z., Guo, J., Wu, Y. & Zhou, Q. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res. 41, 277\u2013287 (2013).","journal-title":"Nucleic Acids Res."},{"key":"59398_CR47","doi-asserted-by":"publisher","first-page":"36609","DOI":"10.1074\/jbc.M112.410746","volume":"287","author":"K Bartholomeeusen","year":"2012","unstructured":"Bartholomeeusen, K., Xiang, Y., Fujinaga, K. & Peterlin, B. M. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J. Biol. Chem. 287, 36609\u201336616 (2012).","journal-title":"J. Biol. Chem."},{"key":"59398_CR48","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","volume":"2","author":"J Zhu","year":"2012","unstructured":"Zhu, J. et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep. 2, 807\u2013816 (2012).","journal-title":"Cell Rep."},{"key":"59398_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/cc.23309","volume":"12","author":"D Boehm","year":"2013","unstructured":"Boehm, D. et al. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 12, 452\u2013462 (2013).","journal-title":"Cell Cycle"},{"key":"59398_CR50","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1073\/pnas.0705053104","volume":"104","author":"DA Bisgrove","year":"2007","unstructured":"Bisgrove, D. A., Mahmoudi, T., Henklein, P. & Verdin, E. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc. Natl. Acad. Sci. USA. 104, 13690\u201313695 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"59398_CR51","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1172\/JCI120633","volume":"129","author":"Q Niu","year":"2019","unstructured":"Niu, Q. et al. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV. J. Clin. Invest. 129, 3361\u20133373 (2019).","journal-title":"J. Clin. Invest."},{"key":"59398_CR52","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1128\/JVI.01880-19","volume":"94","author":"E Alamer","year":"2020","unstructured":"Alamer, E. et al. Epigenetic suppression of HIV in myeloid cells by the BRD4- selective small molecule modulator ZL0580. J. Virol 94, 1880\u201319 (2020).","journal-title":"J. Virol"},{"key":"59398_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-020-00547-9","volume":"18","author":"E Alamer","year":"2021","unstructured":"Alamer, E., Zhong, C., Hajnik, R., Soong, L. & Hu, H. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure. Retrovirology 18, 1\u20139 (2021).","journal-title":"Retrovirology"},{"key":"59398_CR54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos, P. et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214\u2013231 (2012).","journal-title":"Cell"},{"key":"59398_CR55","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"59398_CR56","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: An interactive platform for the analysis and visualization of drug combinations. Bioinformatics 32, 2866\u20132868 (2016).","journal-title":"Bioinformatics"},{"key":"59398_CR57","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1016\/j.febslet.2008.10.047","volume":"582","author":"E Urano","year":"2008","unstructured":"Urano, E. et al. Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells. FEBS Lett 582, 4053\u20134058 (2008).","journal-title":"FEBS Lett"},{"key":"59398_CR58","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1189\/jlb.0312165","volume":"92","author":"C Banerjee","year":"2012","unstructured":"Banerjee, C. et al. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J. Leukoc. Biol. 92, 1147\u20131154 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"59398_CR59","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang, Z. et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19, 535\u2013545 (2005).","journal-title":"Mol. Cell"},{"key":"59398_CR60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","volume":"19","author":"KJ Moon","year":"2005","unstructured":"Moon, K. J. et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19, 523\u2013534 (2005).","journal-title":"Mol. Cell"},{"key":"59398_CR61","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1128\/MMBR.00011-06","volume":"70","author":"Q Zhou","year":"2006","unstructured":"Zhou, Q. & Yik, J. H. N. The yin and yang of P-TEFb Regulation: Implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol. Mol. Biol. Rev. 70, 646\u2013659 (2006).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"59398_CR62","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1074\/jbc.M111.282855","volume":"287","author":"S Schr\u00f6der","year":"2012","unstructured":"Schr\u00f6der, S. et al. Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J. Biol. Chem. 287, 1090\u20131099 (2012).","journal-title":"J. Biol. Chem."},{"key":"59398_CR63","doi-asserted-by":"publisher","first-page":"e12335","DOI":"10.1371\/journal.pone.0012335","volume":"5","author":"BJ Krueger","year":"2010","unstructured":"Krueger, B. J., Varzavand, K., Cooper, J. J. & Price, D. H. The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK. PLoS ONE 5, e12335 (2010).","journal-title":"PLoS ONE"},{"key":"59398_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","volume":"67","author":"RJ Conrad","year":"2018","unstructured":"Conrad, R. J. et al. The short isoform of BRD4 Promotes HIV-1 latency by engaging repressive SWI\/SNF chromatin remodeling complexes. Mol Cell 67, 1001\u20131012 (2018).","journal-title":"Mol Cell"},{"key":"59398_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12046-3","volume":"10","author":"B Lucic","year":"2019","unstructured":"Lucic, B. et al. Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration. Nat. Commun. 10, 1\u201312 (2019).","journal-title":"Nat. Commun."},{"key":"59398_CR66","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1128\/MCB.01365-08","volume":"29","author":"B Huang","year":"2009","unstructured":"Huang, B., Yang, X.-D., Zhou, M.-M., Ozato, K. & Chen, L.-F. Brd4 Coactivates Transcriptional Activation of NF-\u03baB via Specific Binding to Acetylated RelA. Mol. Cell. Biol. 29, 1375\u20131387 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"59398_CR67","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/onc.2013.179","volume":"33","author":"Z Zou","year":"2014","unstructured":"Zou, Z. et al. Brd4 maintains constitutively active NF-\u03baB in cancer cells by binding to acetylated RelA. Oncogene 33, 2395\u20132404 (2014).","journal-title":"Oncogene"},{"key":"59398_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biomedicines6010016","volume":"6","author":"A Hajmirza","year":"2018","unstructured":"Hajmirza, A. et al. BET Family Protein BRD4: An Emerging Actor in NF\u03baB Signaling in Inflammation and Cancer. Biomedicines 6, 16 (2018).","journal-title":"Biomedicines"},{"key":"59398_CR69","doi-asserted-by":"publisher","unstructured":"Janssens, J. et al. Mechanisms and efficacy of small molecule \u201clatency promoting agents\u201d to inhibit HIV reactivation ex vivo. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.183084 (2024).","DOI":"10.1172\/jci.insight.183084"},{"key":"59398_CR70","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1002\/j.1460-2075.1993.tb05994.x","volume":"12","author":"E Verdin","year":"1993","unstructured":"Verdin, E., Paras, P. & Vanlint, C. Chromatin disruption in the promoter of HIV-1 during transcriptional activation. Embo 12, 3249\u20133259 (1993).","journal-title":"Embo"},{"key":"59398_CR71","first-page":"1112","volume":"15","author":"C Van Lint","year":"1996","unstructured":"Van Lint, C., Emiliani, S., Ott, M. & Verdin, E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. The em 15, 1112\u20131120 (1996).","journal-title":"The em"},{"key":"59398_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nsmb.3328","volume":"24","author":"HC Chen","year":"2017","unstructured":"Chen, H. C., Martinez, J. P., Zorita, E., Meyerhans, A. & Filion, G. J. Position effects influence HIV latency reversal. Nat. Struct. Mol. Biol. 24, 47\u201354 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59398_CR73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12038-016-9600-6","volume":"41","author":"B Padmanabhan","year":"2016","unstructured":"Padmanabhan, B., Mathur, S., Manjula, R. & Tripathi, S. Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases. J. Biosci. 41, 295\u2013311 (2016).","journal-title":"J. Biosci."},{"key":"59398_CR74","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41416-020-01077-z","volume":"123","author":"M Ameratunga","year":"2020","unstructured":"Ameratunga, M. et al. First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours. Br. J. Cancer 123, 1730\u20131736 (2020).","journal-title":"Br. J. Cancer"},{"key":"59398_CR75","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","volume":"124","author":"T Shorstova","year":"2021","unstructured":"Shorstova, T., Foulkes, W. D. & Witcher, M. Achieving clinical success with BET inhibitors as anti-cancer agents. Br. J. Cancer 124, 1478\u20131490 (2021).","journal-title":"Br. J. Cancer"},{"key":"59398_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.160267","volume":"7","author":"SF Farhadian","year":"2022","unstructured":"Farhadian, S. F. et al. HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART. JCI Insight 7, 1\u201315 (2022).","journal-title":"JCI Insight"},{"key":"59398_CR77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18889","volume":"5","author":"J Brodin","year":"2016","unstructured":"Brodin, J. et al. Establishment and stability of the latent HIV-1 DNA reservoir. eLife 5, e18889 (2016).","journal-title":"eLife"},{"key":"59398_CR78","doi-asserted-by":"publisher","first-page":"eaaw5589","DOI":"10.1126\/scitranslmed.aaw5589","volume":"11","author":"M-R Abrahams","year":"2019","unstructured":"Abrahams, M.-R. et al. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Sci. Transl. Med. 11, eaaw5589 (2019).","journal-title":"Sci. Transl. Med."},{"key":"59398_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/COH.0000000000000844","volume":"19","author":"E Pellaers","year":"2024","unstructured":"Pellaers, E., Denis, A. & Debyser, Z. New latency-promoting agents for a block-and-lock functional cure strategy. Curr. Opin. HIV AIDS 19, 95\u2013101 (2024).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"59398_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0928-0197(95)00005-S","volume":"4","author":"DV Ablashi","year":"1995","unstructured":"Ablashi, D. V. et al. Human herpesvirus-7 (HHV-7): current status. Clin. Diagn. Virol. 4, 1\u201313 (1995).","journal-title":"Clin. Diagn. Virol."},{"key":"59398_CR81","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","volume":"22","author":"A Jordan","year":"2003","unstructured":"Jordan, A. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22, 1868\u20131877 (2003).","journal-title":"EMBO J"},{"key":"59398_CR82","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/JVI.72.5.3623-3634.1998","volume":"72","author":"I Mondor","year":"1998","unstructured":"Mondor, I., Ugolini, S. & Sattentau, Q. J. Human immunodeficiency virus type 1 attachment to hela CD4 cells is CD4 Independent and gp120 dependent and requires cell surface heparans. J. Virol. 72, 3623\u20133634 (1998).","journal-title":"J. Virol."},{"key":"59398_CR83","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1128\/JVI.00709-09","volume":"83","author":"EJ Platt","year":"2009","unstructured":"Platt, E. J., Bilska, M., Kozak, S. L., Kabat, D. & Montefiori, D. C. Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J. Virol. 83, 8289\u20138292 (2009).","journal-title":"J. Virol."},{"key":"59398_CR84","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1128\/jvi.59.2.284-291.1986","volume":"59","author":"A Adachi","year":"1986","unstructured":"Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284\u2013291 (1986).","journal-title":"J. Virol."},{"key":"59398_CR85","doi-asserted-by":"crossref","unstructured":"Ibrahimi, A. et al. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Human Gene Therapy. 20, 845\u2013860 (2009).","DOI":"10.1089\/hum.2008.188"},{"key":"59398_CR86","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jgm.778","volume":"7","author":"M Geraerts","year":"2005","unstructured":"Geraerts, M., Micheils, M., Baekelandt, V., Debyser, Z. & Gijsbers, R. Upscaling of lentiviral vector production by tangential flow filtration. J. Gene Med. 7, 1299\u20131310 (2005).","journal-title":"J. Gene Med."},{"key":"59398_CR87","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nprot.2007.517","volume":"3","author":"C Pannecouque","year":"2008","unstructured":"Pannecouque, C., Daelemans, D. & De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: Revisited 20 years later. Nat. Protoc. 3, 427\u2013434 (2008).","journal-title":"Nat. Protoc."},{"key":"59398_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope: A novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22\u201329 (2012).","journal-title":"J. Mol. Diagn."},{"key":"59398_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01693-z","volume":"8","author":"M Puray-Chavez","year":"2017","unstructured":"Puray-Chavez, M. et al. Multiplex single-cell visualization of nucleic acids and protein during HIV infection. Nat. Commun. 8, 1\u201311 (2017).","journal-title":"Nat. Commun."},{"key":"59398_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1006\/jcis.1996.0217","volume":"179","author":"J Crocker","year":"1995","unstructured":"Crocker, J. & Grier, D. Methods of digital video microscopy for colloidal studies | Elsevier enhanced reader. J. Colloid Interface Sci. 179, 298\u2013310 (1995).","journal-title":"J. Colloid Interface Sci."},{"key":"59398_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00158","volume":"8","author":"KR Roell","year":"2017","unstructured":"Roell, K. R., Reif, D. M. & Motsinger-Reif, A. A. An introduction to terminology and methodology of chemical synergy-perspectives from across disciplines. Front. Pharmacol. 8, 1\u201311 (2017).","journal-title":"Front. Pharmacol."},{"key":"59398_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-38907-x","volume":"9","author":"M Sinzger","year":"2019","unstructured":"Sinzger, M., Vanhoefer, J., Loos, C. & Hasenauer, J. Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible. Sci. Rep. 9, 1\u201315 (2019).","journal-title":"Sci. Rep."},{"key":"59398_CR93","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav, B., Wennerberg, K., Aittokallio, T. & Tang, J. Searching for drug synergy in complex dose-response landscapes using an interaction potency model. Comput. Struct. Biotechnol. J. 13, 504\u2013513 (2015).","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59398-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59398-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59398-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T10:03:08Z","timestamp":1746612188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59398-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59398"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59398-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4226"}}